Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, Topics Apr 24 | 2018Sanofi’s Head of Global R&D RetiringPurchase Blast
$599
Posted in: Basal Insulin, Topics Apr 23 | 2018New Oramed Oral Insulin Ph2b Study InitiatedPurchase Blast
$599
Posted in: Glucose Monitoring, SGLT2i, Topics Apr 17 | 2018J&J Q1 '18 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Topics Apr 17 | 2018Livongo Acquires Digital Obesity CompanyPurchase Blast
$599
Posted in: SGLT2i, Topics Apr 16 | 2018BI/Lilly to Initiate New Jardiance CKD StudyPurchase Blast
$599
Posted in: GLP-1RA, Topics Apr 16 | 2018New Trulicity High-Dose Ph3 Study (AWARD-11)Purchase Blast
$599
Posted in: Insulin Delivery, Topics Apr 13 | 2018Common Sensing and Haselmeier ThoughtsPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Apr 11 | 2018Livongo partners with Cambia Health Solutions and raises $105MPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, Topics Apr 11 | 2018Mylan IR Day Highlights; Biosimilar Victoza and Toujeo in DevelopmentPurchase Blast
$599
Posted in: Glucagon, Topics Apr 11 | 2018Zealand and Roche Partner for Ph3 stable glucagon development in CHIPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Apr 05 | 2018Ascensia Contour NEXT access expanded on UHCPurchase Blast
$599
Posted in: Other, Topics Apr 04 | 2018Lilly invests in beta cell encapsulation developmentPurchase Blast
$599
Posted in: Basal Insulin, GLP-1RA, Topics Apr 03 | 2018Bydureon Approved as Add-On to Basal InsulinPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Mar 30 | 2018iCGM FDA “Special Controls” AnalysisPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Mar 29 | 2018FENIX Analysis: Thoughts on Dexcom G6 ApprovalPurchase Blast
$599
Posted in: Glucose Monitoring, Topics Mar 27 | 2018FENIX Analysis: Senseonics FDA Adcom Briefing Documents; Dexcom G6 ApprovalPurchase Blast
